Keywords: عامل انتینوپلاستی; Prostatic neoplasms; Lymphatic metastasis; Prostatectomy; Prognosis; Adjuvant radiotherapy; Antineoplastic agents; Hormonal; Mortality;
مقالات ISI عامل انتینوپلاستی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Aging; Cognition; Neoplasms; Rehabilitation; BIC; Bayesian information criterion; HRS; Health and Retirement Study; LCGA; latent class growth analysis;
Keywords: عامل انتینوپلاستی; Head and neck neoplasms; Salivary glands; Parotid gland; Salivary ducts; Radiation; Antineoplastic agents; Surgical procedures; Operative procedures;
Keywords: عامل انتینوپلاستی; Anal cancer; Anus neoplasms; Radiotherapy; Intensity-modulated radiotherapy; Volumetric-modulated arc therapy; Chemoradiotherapy; Antineoplastic agents; Toxicity;
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Cardiotoxicity; Perioperative care; Anesthesia; General; Heart function tests;
Keywords: عامل انتینوپلاستی; Breast neoplasms; Antineoplastic agents; Hormonal biological products; Biological markers; Disease-free survival;
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Costs and cost analysis; Drug-related side effects and adverse reactions; Treatment outcome; Immunotherapy; Molecular targeted therapy;
Keywords: عامل انتینوپلاستی; prostatic neoplasms; androgen antagonists; antineoplastic agents; hormonal; drug related side effects and adverse reactions; risk; ADT; androgen deprivation therapy; AMI; acute myocardial infarction; CADT; continuous ADT; GnRH; gonadotropin-releasing horm
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Clinical trials; Drug therapy; Protein tyrosine kinase antagonists/inhibitors; Review
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Trace elements; Apoptosis; Lipid peroxidation
Keywords: عامل انتینوپلاستی; Esophageal neoplasms; Selective estrogen receptor modulators; Antineoplastic agents; Estrogen receptors; ER; estrogen receptor; 5-FU; 5-fluorouracil; MTS; 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium); RPMI; Ros
Keywords: عامل انتینوپلاستی; Gastric neoplasms; Angiogenesis inhibitors; Antineoplastic agents; Vascular endothelial growth factor antagonists and inhibitors; Controlled clinical trial; Antineoplastic combined chemotherapy protocols;
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Drug costs; Oral anticancer medications; Renal cell carcinoma; Treatment patterns;
Keywords: عامل انتینوپلاستی; Anti-proliferative activity; Antineoplastic agents; Cell death; Cytotoxicity; Human cancer cell lines; Marine-derived fungi
Keywords: عامل انتینوپلاستی; Decision making; Health technology assessment; Drug reimbursement; Antineoplastic agents;
Keywords: عامل انتینوپلاستی; Diarylacetylenes; Colon cancer; Antineoplastic agents; c-myc;
Keywords: عامل انتینوپلاستی; myeloproliferative neoplasm; leukemic transformation; leukemia etiology; polycythemia vera; essential thrombocythemia; primary myelofibrosis; antineoplastic agents; alkylators; hydroxyurea; radioactive phosphorous; X-ray treatment; JAK2 mutation; risk fac
Keywords: عامل انتینوپلاستی; Breast neoplasms; Antineoplastic agents; Adverse effects; Antineoplastic agents; Therapeutic use; Patient-centered care; Patient-preference; Patient adherence;
Keywords: عامل انتینوپلاستی; Tanshinone; Salviae Miltiorrhiza; Antineoplastic agents; Apoptosis; Cell line; tumor
Médicaments et cicatrisation
Keywords: عامل انتینوپلاستی; anticancéreux; anti-inflammatoire non stéroïdien; cicatrisation; effet indésirable médicamenteux; immunosuppresseur; nicorandil; adverse drug reaction; antineoplastic agents; immunosuppressant drugs; nicorandi; Non Steroidal Anti Inflammatory Drug; w
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057
Keywords: عامل انتینوپلاستی; Carcinoma; Non-small cell lung; Lung neoplasms; Docetaxel; Surveys and questionnaires; Quality of life; Nivolumab; Antineoplastic agents;
Topical Chemotherapy and the Evolving Role of the Biopsy for Ocular Surface Squamous Neoplasia
Keywords: عامل انتینوپلاستی; Ocular surface squamous neoplasia; OSSN; Carcinoma in situ; Squamous cell carcinoma; Conjunctiva; Biopsy; Anterior segment optical coherence tomography; Antineoplastic agents;
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis
Keywords: عامل انتینوپلاستی; Cystectomy; Urinary bladder neoplasms; Neoadjuvant therapy; Antineoplastic agents; Cisplatin;
Targeting MET in cancer therapy
Keywords: عامل انتینوپلاستی; Proto-oncogene protein c-MET; Antineoplastic agents; Protein kinase inhibitors; Molecular targeted therapy;
Methanolic extract from Lespedeza bicolor: potential candidates for natural antioxidant and anticancer agent
Keywords: عامل انتینوپلاستی; Lespedeza; Antineoplastic agents; Antioxidants; Anti-infective agents;
15d-PGJ2 as an endoplasmic reticulum stress manipulator in multiple myeloma in vitro and in vivo
Keywords: عامل انتینوپلاستی; Multiple myeloma; Antineoplastic agents; Prostaglandins; Unfolded protein response; Endoplasmic reticulum stress; Peroxiredoxins; Apoptosis;
Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients
Keywords: عامل انتینوپلاستی; Testicular neoplasms; Survivors; Antineoplastic agents; HFE; Bleomycin; Cisplatin; Toxicity; Variation
Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors
Keywords: عامل انتینوپلاستی; Testicular neoplasms; Survivors; Antineoplastic agents; Testosterone; 3-Oxo-5-alpha-steroid 4-dehydrogenase; Single-nucleotide polymorphism; Metabolic syndrome X; Carotid intima-media thickness; Albuminuria;
A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway
Keywords: عامل انتینوپلاستی; formularies; homeopathic; antineoplastic agents; telomerase; DNA topoisomerases; type II; membrane potential; mitochondrial;
Perception des effets indésirables de la chimiothérapie et de l'hormonothérapie par les femmes prises en charge pour un cancer du sein
Keywords: عامل انتینوپلاستی; Breast cancer; Antineoplastic agents; Adverse drug reaction; General practitioner; Cancer du sein; Médicaments antinéoplasiques; Effets indésirables; Médecin généraliste;
Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469
Keywords: عامل انتینوپلاستی; XK469; Quinoxaline peptidomimetic analogues; Hydrophobic chain; Topoisomerase II inhibitor; Antineoplastic agents;
Chemotherapy Use and Surgical Treatment by Receptor Subtype in Node-Negative T1a and T1b Female Breast Cancers, Iowa SEER Registry, 2010- to 2012
Keywords: عامل انتینوپلاستی; Antineoplastic agents; Breast neoplasms; Cancer registry; Mastectomy; Small tumor;
Czynniki warunkujÄ
ce aktywnoÅÄ terapeutycznÄ
L-asparaginazy
Keywords: عامل انتینوپلاستی; leki przeciwnowotworowe; biaÅaczka; wyniki leczenia; pediatria; Antineoplastic agents; Leukemia; Treatment outcome; Pediatrics;
Association of reimbursement policy and urologists׳ characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer1
Keywords: عامل انتینوپلاستی; Prostatic neoplasms; Antineoplastic agents; Hormonal; Health services research; SEER program; Physician׳s role;
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma - Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
Keywords: عامل انتینوپلاستی; Carcinoma; Hepatocellular; Fibrolamellar hepatocellular carcinoma; Hepatoma; Clinical oncology; Paediatrics; Liver neoplasms; Liver diseases; Neoplasms; Antineoplastic agents;
A phase II study of mitomycin, fluorouracil, folinic acid, and irinotecan (MFI) for the treatment of transitional cell carcinoma of the bladder
Keywords: عامل انتینوپلاستی; Bladder cancer; Mitomycin; Camptothecin analogues; Fluorouracil; Antineoplastic agents
Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment
Keywords: عامل انتینوپلاستی; Peritoneal neoplasms; Colorectal neoplasms; Hyperthermia; Antineoplastic agents; Treatment outcome; Humans;
Chimiothérapie anticancéreuse et grossesse
Keywords: عامل انتینوپلاستی; Pregnancy prevention; cancer; neoplasms; pregnancy; chemotherapy; antineoplastic agents;
Targeted Agent Use in Cancer Patients at the End of Life
Keywords: عامل انتینوپلاستی; Antineoplastic agents; end of life; palliative care; quality of care; supportive care; targeted agents
Assessment of an automatic robotic arm for dispensing of chemotherapy in a 2500-bed medical center
Keywords: عامل انتینوپلاستی; antineoplastic agents; health manpower; hospital; pharmacy service; robotics
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer
Keywords: عامل انتینوپلاستی; Aromatase inhibitors; Breast cancer; Elderly; Exemestane; Metastatic; Tamoxifen; Antineoplastic agents; Hormonal
Investigations on nanoconfinement of low-molecular antineoplastic agents into biocompatible magnetic matrices for drug targeting
Keywords: عامل انتینوپلاستی; Biocompatible host matrices; Magnetic nanoparticles; Mesoporous silica; Antineoplastic agents; Nanoconfinement
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies
Keywords: عامل انتینوپلاستی; MAP kinase kinase 1; MAP kinase kinase 2; Pharmacology; Pharmacokinetics; Dose–response relationship, Drug; Clinical trials, Phase I; Neoplasms; Antineoplastic agents; Cohort studies; Maximum tolerated dose
Cancer Chemotherapy and Pregnancy
Keywords: عامل انتینوپلاستی; Pregnancy prevention; cancer; neoplasms; pregnancy; chemotherapy; antineoplastic agents;
Synthesis and biological evaluation of conjugates of deoxypodophyllotoxin and 5-FU as inducer of caspase-3 and -7
Keywords: عامل انتینوپلاستی; Podophyllotoxin; 5-FU; Antineoplastic agents; Apoptosis; Caspase
Occupational exposures among nurses and risk of spontaneous abortion
Keywords: عامل انتینوپلاستی; antineoplastic agents; health personnel; occupational exposure; pregnancy;
Antineoplastic agents extravasation from peripheral intravenous line in children: A simple strategy for a safer nursing care
Keywords: عامل انتینوپلاستی; Extravasation; Antineoplastic agents; Children; Oncology nursing; Safety; Intravenous therapy; Pediatric nursing; Medication errors; Quality of care; Evidence-based nursing;
Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice
Keywords: عامل انتینوپلاستی; Docetaxel; Interferon-alpha; P-glycoprotein; Antineoplastic agents; Lung neoplasms; Lewis lung carcinoma;
Metal complexes as inhibitors of the 26S proteasome in tumor cells
Keywords: عامل انتینوپلاستی; Metal complex; Proteasome; Antineoplastic agents
Novel Agents and Approaches for Advanced Renal Cell Carcinoma
Keywords: عامل انتینوپلاستی; kidney; carcinoma; renal cell; immunomodulation; antineoplastic agents; clinical trials as topicAE, adverse event; BID, twice daily; CR, complete response; FGFR, fibroblast growth factor receptor; IFN, interferon; mRCC, metastatic renal cell carcinoma; mT